Orilanolimab
Orilanolimab Basic information
- Product Name:
- Orilanolimab
- Synonyms:
-
- Orilanolimab
- Research Grade Orilanolimab (DHF14601)
- Research Grade Orilanolimab
- CAS:
- 2066544-85-0
- MW:
- 0
- Mol File:
- Mol File
Orilanolimab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
Orilanolimab Usage And Synthesis
Uses
Orilanolimab (SYNT001) is a humanized, de-immunized and FcRn-blocking monoclonal antibody. Orilanolimab blocks the interaction between FcRn and the Fc portion of IgG molecules. Orilanolimab impedes IgG IC activation of the FcRn-mediated adaptive immune function. And Orilanolimab disrupts the associated pathways related to IgG homeostasis and innate and adaptive immunity[1][2].
in vivo
Orilanolimab (20 mg/kg; i.v.) significantly reduces the plasma concentration of HuLys11 in mouse model[1].
Orilanolimab (10-100 mg/kg; i.v.; once per 5 weeks) causes dose-dependent and specific reduction of total circulating levels of IgG cynomolgus monkeys[1].
References
[1] Blumberg LJ, et al. Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses. Sci Adv. 2019 Dec 18;5(12):eaax9586. DOI:10.1126/sciadv.aax9586
[2] Blumberg L, et al. SYNT001: a humanized IgG4 monoclonal antibody that disrupts the interaction of FcRn and IgG for the treatment of IgG-mediated autoimmune diseases[J]. Blood, 2017, 130: 3483.
OrilanolimabSupplier
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 15817493340
- 981810490@qq.com
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com